Sign in
4/A

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001654954-23-009596

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Marshall Patrick · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-20 Grant or award : show line 1 in the form Share Option (right to buy) +20,000 20,000 D
Loading xslF345X05/section16.xml…